Colorectal cancer is common enough in China that its surgical teams have refined both operations — the colon operation and the rectal one — through sheer volume. But the thing worth understanding before you compare prices is that the two are planned completely differently, and the difference is not the stage. It is the address.
Our dedicated colorectal cancer page collects the pathways, hospitals and reference costs in one place; this post explains how the plan is set.
1. The Question That Decides the Operation
Where is the tumour? The colon and the rectum behave differently enough that they are treated as two diseases with two sets of guidelines.
A tumour in the colon is usually an operation first. The segment carrying the tumour is removed and the bowel rejoined, and because the colon has room to work with, the join is normally straightforward. Chemotherapy follows afterwards if the stage calls for it.
A tumour in the rectum is a different problem, because the rectum sits in the pelvis, close to the anal sphincter, and there is far less room. That constraint drives everything: whether radiation is used, whether chemotherapy comes first, and whether the sphincter can be saved.
This is why two patients both told "stage III" can be given completely different plans, and why "how advanced is it" is the less useful first question.
2. How the Tumour's Height Changes the Operation
Upper and middle rectum. There is usually enough length to remove the tumour and rejoin the bowel, keeping the sphincter. This is a sphincter-preserving resection, and it is the preferred outcome where it is achievable.
Very low rectum. If the tumour sits too close to the sphincter, the margin needed for a safe removal leaves nothing to join back to. The operation is then an abdominoperineal resection, which removes the rectum and the anal sphincter and leaves a permanent colostomy — a stoma on the abdominal wall, with a bag.
Whether sphincter preservation is possible depends on three things, and none of them can be settled in advance from a website: tumour height, how much the tumour shrank in response to chemoradiotherapy, and your pelvic anatomy.
3. The Treatment Path by Stage
Early disease is confined to the bowel wall. Surgery is the treatment, and if the tumour is at a very early stage confined to the innermost layer, it may sometimes be removed through the colonoscope without an abdominal operation. At high-volume Chinese centres, colectomy is increasingly performed laparoscopically, which shortens the hospital stay.
Locally advanced disease has grown through the bowel wall or reached nearby lymph nodes, without spreading to distant organs. In the colon, surgery comes first and chemotherapy follows. In the rectum, the order commonly reverses: chemotherapy with radiotherapy is given before surgery to shrink the tumour, which is what makes sphincter preservation more often achievable. Surgery follows, then further chemotherapy.
Metastatic disease has spread, most often to the liver or lungs. Treatment shifts to systemic control rather than cure. For a minority of patients with limited liver deposits, surgery on both sites may still be considered — this is assessed case by case.
4. The Tests That Decide Your Drugs
This is the part patients most often skip, and it is the part that determines the bill.
MMR/MSI status. Tumours that are MSI-high or dMMR respond to immunotherapy, and for that group it can be the most effective option available. Tumours that are not do not.
RAS and BRAF mutation status. Anti-EGFR agents such as cetuximab only help RAS wild-type tumours. Testing RAS before offering the drug is standard, because in a mutated tumour it adds cost and side effects without benefit.
Those results, together with your stage, decide the regimen. The standard chemotherapy backbones are FOLFOX or FOLFIRI. Bevacizumab is a common addition. Which of these applies to you is not a matter of hospital preference — it follows from the pathology.
5. What It Costs
Our published reference ranges. These are estimates; the final quote comes from the hospital after it reviews your pathology and staging scans.
| What is counted | China reference | US reference |
|---|---|---|
| Colorectal cancer surgery | $12,000–$20,000 | $60,000–$100,000 |
| Full treatment course (surgery + chemotherapy, plus radiotherapy if rectal) | $25,000–$50,000 | $120,000–$200,000 |
The gap between the rows is the same one patients underestimate everywhere: surgery is the visible cost, but a full course adds chemotherapy cycles, and for rectal cancer a five-to-six-week chemoradiotherapy course before the operation.
For context on outcomes rather than price, five-year survival for colorectal cancer is reported at 64% in the United States against 58–65% at Chinese centres. Group figures like these tell you about populations, not about you — your own outlook depends on your stage and biology.
6. Where Colorectal Cancer Is Handled
Our directory records the following centres. Every one is recorded as offering international patient services.
- Cancer Hospital, CAMS (Beijing) — recorded in our directory as first in oncology nationally, and the reference point for complex oncology in China. See CAMS.
- Sun Yat-sen University Cancer Center (Guangzhou) — recorded in the national top three for cancer care, and a high-volume southern centre. See Sun Yat-sen.
- Fudan University Shanghai Cancer Center (Shanghai) — also recorded in the national top three, and repeatedly named among China's strongest colorectal surgery departments. See Fudan Cancer Center.
- Zhongshan Hospital (Shanghai) — recorded as a leading digestive-disease centre. See Zhongshan.
The criteria we apply, and what we do not claim, are set out on our methodology page.
7. What This Does Not Promise
Three honest limits, because a treatable cancer invites overstatement:
- No one can promise the sphincter will be saved. It is the question patients care about most and the one least answerable in advance. It depends on tumour height, response to chemoradiotherapy and pelvic anatomy, and a surgeon has to assess you — often after the pre-operative treatment has done its work.
- A stoma is not a failure of the treatment. For a very low rectal tumour, an abdominoperineal resection with a permanent colostomy can be the operation that offers a cure. It is worth talking to a stoma nurse before surgery, not after.
- The prices are ranges, not quotes. Your final figure depends on the site of the tumour and the drugs your regimen uses. Get it in writing before committing.
The useful frame is this: the value of travelling is volume and speed — high-volume centres where the rectal operation, including the decision about the sphincter, is routine — not a promise that your outcome will differ.
8. Frequently Asked Questions
How much does colorectal cancer treatment cost in China?
Our published reference ranges: colorectal cancer surgery runs $12,000–$20,000 in China against $60,000–$100,000 in the US, and a full treatment course runs $25,000–$50,000 against $120,000–$200,000. The final quote depends on the site of the tumour, the stage, and which drugs the regimen uses.
Will I need a permanent stoma?
Sometimes, and it depends mainly on how low the tumour sits. Tumours in the upper and middle rectum can usually be removed with a sphincter-preserving operation that joins the bowel back together. Tumours very low in the rectum may need an abdominoperineal resection, which removes the anal sphincter and leaves a permanent colostomy. Whether the sphincter can be kept depends on tumour height, how the tumour responded to chemoradiotherapy, and your pelvic anatomy — assessed from your MRI and endoscopy by a high-volume centre.
Does chemotherapy come before surgery for colorectal cancer?
It depends on the site. Colon cancer is usually treated with surgery first, followed by chemotherapy if the stage warrants it. Locally advanced rectal cancer commonly receives chemotherapy and radiotherapy before surgery, which is called neoadjuvant treatment. That can shrink the tumour and make a sphincter-preserving operation more likely. The order is set from your staging scans.
Which tests decide which drugs I am offered?
Molecular testing on the tumour. MMR/MSI status tells you whether immunotherapy is likely to work — MSI-high or dMMR tumours respond to it. RAS and BRAF mutation testing tells you whether an anti-EGFR agent such as cetuximab is worth using, because it only helps RAS wild-type tumours. Standard chemotherapy backbones are FOLFOX or FOLFIRI, and bevacizumab is a common addition. Without these results a drug plan is guesswork, and the tests are cheap next to the drugs they rule in or out.
Which hospitals in China treat colorectal cancer?
Our directory records the Cancer Hospital of CAMS in Beijing as first in oncology nationally, Sun Yat-sen University Cancer Center in Guangzhou and Fudan University Shanghai Cancer Center both in the national top three, and Zhongshan Hospital in Shanghai as a leading digestive-disease centre. All are recorded as offering international patient services. A case review confirms which of them fits your stage and timing.
How long does treatment take in China?
Records and imaging can be reviewed before you travel, and a plan is typically agreed within two to four weeks. A colectomy involves roughly a week in hospital, and a surgical episode including recovery is usually planned as three to four weeks in China. If your plan starts with chemoradiotherapy, that course runs about five to six weeks before surgery, and chemotherapy cycles commonly run every two to three weeks.
Get a Free Colorectal Cancer Case Review
Send your pathology report, staging scans and molecular results. We'll tell you which of the centres above fits your stage, clarify whether chemotherapy is likely to come before surgery in your case, and outline what a written quote would cover. No obligation, 100% confidential, we reply within 24 hours.
- 📧 Email: contact@chinahospitalsguide.com
- 💬 WhatsApp: +86 157 6310 7083
- 📨 Telegram: @chinahospitalguide
- 💬 WeChat: chinahospitalguide
- 🌐 Start Free Case Review
Medical Disclaimer This article is general educational content and does not constitute medical advice, a treatment recommendation, or an invitation to seek care. It cannot replace an in-person consultation with a licensed physician. Cost figures are our published reference ranges for international patients and are not guarantees; final quotes come from the hospital after review of your pathology and imaging. Whether a particular operation or regimen is suitable must be assessed by a qualified multidisciplinary team.
Source disclosure The staging and treatment framework follows the NCCN Clinical Practice Guidelines for colon and rectal cancer and AJCC 8th edition staging. Hospital rankings are as recorded in our own directory from publicly available national rankings, and are statements about our records rather than independent assessments of clinical quality. Cost ranges are from China Hospitals Guide's published cancer treatment cost guide. China Hospitals Guide is an independent hospital-matching platform and does not accept commissions from hospitals.
Related Reading
- Colorectal Cancer Treatment Cost in China 2026
- Stomach Cancer Treatment in China 2026: Partial or Total Gastrectomy
- Breast Cancer Treatment in China 2026: Surgery, Reconstruction or Systemic Therapy
- Cancer Treatment Cost in China: What Surgery, Radiotherapy and Drugs Actually Add Up To
- How We Choose Hospitals
